
Altimmune, Inc. (NASDAQ:ALT) reported its second-quarter financial results before Tuesday’s opening bell.
Below are the transcripts from the Q2 earnings call.

Altimmune, Inc. (NASDAQ:ALT) reported its second-quarter financial results before Tuesday’s opening bell.
Below are the transcripts from the Q2 earnings call.